QUINCE
Live / Registered — Registered (as of 20 May 2025)
What this means for you
Registered since 20 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97385224
- Registration number
- 7803872
- Mark type
- Stylized text
- Filed
- 27 Apr 2022
- Published for opposition
- 13 Jun 2023
- Registered
- 20 May 2025
- Attorney of record
- Jeffrey Greene
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, medicinal and biological preparations for the treatment and prevention of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
- Class 042 — Scientific and technological services: Medical and scientific research; pharmaceutical research and development; pharmaceutical and biological research; pharmaceutical testing; pharmaceutical product development consultation; scientific research in the nature of conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, arthritis, infectious disease, genetic disease, autoimmune disease, inflammatory disease, diabetes, cardiovascular disease, cancer, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Owner
- QUINCE THERAPEUTICS, INC., South San Francisco, CA, US
- QUINCE THERAPEUTICS, INC., South San Francisco, CA, US
- QUINCE THERAPEUTICS, INC., SOUTH SAN FRANCISCO, CA, US
- Cortexyme, Inc., South San Francisco, CA, US
Prosecution history
- 20 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 28 Apr 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Apr 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Apr 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Feb 2025 — USE AMENDMENT FILED
- 14 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 04 Feb 2025 — SOU EXTENSION 3 GRANTED
- 04 Feb 2025 — SOU EXTENSION 3 FILED
- 04 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED